This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2020.
Company Filing History:
1 out of 834,411 Years Active: 2020
Title: Katja Kristan: Innovator in Pharmaceutical Formulations
Introduction
Katja Kristan is a notable inventor based in Ljubljana, Slovenia. She has made significant contributions to the field of pharmaceutical formulations, particularly with her innovative work on afatinib-containing formulations. Her research focuses on improving the solubility and delivery of this important compound.
Latest Patents
Katja Kristan holds a patent for an afatinib-containing formulation. The patent describes a process for preparing granules or particles comprising afatinib dimaleate. This process involves providing afatinib dimaleate along with at least one pharmaceutically acceptable excipient. The preparation of granules or particles utilizes at least one solvent selected from organic solvents and water. All excipients used in the process have neutral or acidic properties, and afatinib dimaleate exhibits a solubility of at least 5 mg/ml in the chosen solvent. The invention also includes granules or particles prepared according to this process, as well as a pharmaceutical composition for treating certain diseases.
Career Highlights
Throughout her career, Katja Kristan has demonstrated a strong commitment to advancing pharmaceutical science. Her innovative approach to formulation development has positioned her as a key figure in her field. With her patent, she has contributed to the ongoing efforts to enhance drug delivery systems.
Collaborations
Katja has collaborated with several professionals in her field, including Jan Pelipenko and Marko Oblak. These collaborations have further enriched her research and development efforts.
Conclusion
Katja Kristan is a pioneering inventor whose work on afatinib-containing formulations has the potential to significantly impact pharmaceutical treatments. Her contributions to the field exemplify the importance of innovation in healthcare.